Related Experiment Video
Updated: Nov 24, 2025

Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Published on: September 25, 2018
One-step determination of deletion mutation based on loop-mediated isothermal amplification.
Xiaonan Liu1, Chao Zhang1, Sinong Zhang1
1College of Life Sciences, Northwest University, Xi'an, Shaanxi, 710069, China.
A new one-step assay accurately identifies deletion mutations using loop-mediated isothermal amplification. This rapid method aids precision medicine by detecting cancer-related genetic variants in clinical samples.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Deletion mutations are key drivers in disease development, particularly in cancer.
- Precision medicine necessitates efficient and specific methods for detecting deletion mutations.
- Current diagnostic approaches may lack the speed or sensitivity required for clinical practice.
Purpose of the Study:
- To develop a straightforward, sequence-specific, one-step assay for deletion mutation identification.
- To establish a rapid and ultrasensitive method for clinical application in cancer diagnostics.
- To demonstrate the assay's utility in identifying clinically relevant deletion mutations.
Main Methods:
- Utilized loop-mediated isothermal amplification (LAMP) for sensitive DNA amplification.
- Designed tailor-made primer sets for specific detection of deletion mutations.
- Validated the assay using cell lines and clinical samples, including EGFR p.E746-A750del.
Main Results:
- Achieved ultrasensitive detection of as low as 30 copies or 0.1% target variants.
- Demonstrated accurate identification of deletion mutations within 30 minutes under challenging conditions.
- Successfully identified the epidermal growth factor receptor (EGFR) p.E746-A750del mutation in non-small-cell lung cancer samples.
Conclusions:
- The developed LAMP-based assay is a rapid, sensitive, and specific tool for deletion mutation detection.
- This method holds potential as a molecular diagnostic tool for cancer diagnosis, therapy, and prognosis.
- The assay is adaptable for point-of-care testing scenarios, supporting personalized cancer treatment strategies.
More Related Videos
06:11Author Spotlight: Advancing Rapid Detection of Respiratory Pathogens Using Microfluidic Chip
Published on: March 29, 2024
10:41Wild-type Blocking PCR Combined with Direct Sequencing as a Highly Sensitive Method for Detection of Low-Frequency Somatic Mutations
Published on: March 29, 2017